"A morning cortisol is the most effective clinical predictor of short synacthen test outcome": A tertiary care centre experience.
adrenal insufficiency
morning cortisl level
short synacthen test
Journal
Clinical endocrinology
ISSN: 1365-2265
Titre abrégé: Clin Endocrinol (Oxf)
Pays: England
ID NLM: 0346653
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
revised:
17
05
2023
received:
21
02
2023
accepted:
21
05
2023
medline:
6
7
2023
pubmed:
8
6
2023
entrez:
8
6
2023
Statut:
ppublish
Résumé
Increasing referrals to Endocrinology with nonspecific symptoms of suspected adrenal insufficiency (AI) has increased use of the short-synacthen test (SST). Prevailing resource and safety concerns emphasise importance of patient selection criterion to optimise SST use. This study aimed to (1) document the adverse event profile of the SST (2) identify any pretest predictors of SST outcome. Retrospective data analysis of all patients referred for SST in Oxford from 2017 to 2021. Pretest clinical variables (age, sex, BMI, blood pressure and electrolytes), symptoms (fatigue, dizziness, weight loss) and pretest morning cortisol were included in the statistical model with the aim of identifying any variables that could predict SST outcome in Group 1 primary AI, Group 2 central AI and Group 3 glucocorticoid induced AI. Symptoms and signs during and post SST were also noted with the aim of describing adverse effects to synacthen across a large cohort. A total 1480 SSTs (Males:38%, age 52 [39-66] years) were performed: 505 (34.1%) in Group 1, 838 (57%) in Group 2, and 137 (9.3%) in Group 3. Adverse-effects were recorded in 1.8% of tests, including one episode of anaphylaxis. Pretest morning-cortisol was the only predictor for an "SST pass" (whole cohort: B = 0.015, p < 0.001, Group 1: B = 0.018, p < .001; Group 2: B = 0.010, p < 0.012; Group 3: B = 0.018, p = <.001). A threshold of ≥343 nmol/l (receiver-operating characteristic [ROC] area under the curve [AUC] = 0.725, 95% confidence interval [CI] 0.675-0.775, p < 0.001) for the whole cohort, ≥300 nmol/L (ROC AUC = 0.763, 95% CI 0.675 to 0.850, p < 0.001) for Group 1, ≥340 nmol/L (ROC AUC = 0.688, 95% CI 0.615 to 0.761, p < 0.001) for Group2, and ≥376 nmol/L [baseline cortisol] (ROC AUC = 0.783, 95% CI 0.708 to 0.859, p < 0.001) for Group 3, predicted an 'SST pass' with 100% specificity. Adverse effects to synacthen are rare. Pretest morning cortisol is a reliable predictor for SST outcome and is a helpful tool to rationalise use of the SST. Predictive morning-cortisol thresholds vary according to the aetiology of AI.
Substances chimiques
Hydrocortisone
WI4X0X7BPJ
Glucocorticoids
0
Cosyntropin
16960-16-0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
142-151Informations de copyright
© 2023 The Authors. Clinical Endocrinology published by John Wiley & Sons Ltd.
Références
Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet. 2014;383(9935):2152-2167.
Oelkers W. Adrenal insufficiency. N Engl J Med. 1996;335(16):1206-1212.
Bleicken B, Ventz M, Quinkler M, Hahner S. Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients. Am J Med Sci. 2010;339(6):525-531.
Stacey M, Gifford RM, Woods D. Safer care for patients with adrenal insufficiency: weighing the evidence, balancing risks and acknowledging uncertainties. Clin Med. 2021;21(5):e541-e542.
Hanna FWF, Issa BG, Kevil B, Fryer AA. Investigating cortisol excess or deficiency: a practical approach. BMJ. 2019;367:l6039.
Agha A, Tomlinson JW, Clark PM, Holder G, Stewart PM. The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis. J Clinical Endocrinology & Metabolism. 2006;91(1):43-47.
Grossman AB. Clinical review#: the diagnosis and management of central hypoadrenalism. J Clin Endocrinol Metab. 2010;95(11):4855-4863.
Arlt W. The approach to the adult with newly diagnosed adrenal insufficiency. J Clin Endocrinol Metabol. 2009;94(4):1059-1067.
Grossman AB. Position statement on the use of synthetic ACTH (Synacthen) in patients with a history of asthma. 2011. www.endocrinology.org/media/1783/11-09_syntheticacth_in_patients_with_asthma.pdf
Woods CP, Argese N, Chapman M, et al. Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol. Eur J Endocrinol. 2015;173(5):633-642.
Yo WS, Toh LM, Brown SJ, Howe WD, Henley DE, Lim EM. How good is a morning cortisol in predicting an adequate response to intramuscular synacthen stimulation? Clin Endocrinol. 2014;81(1):19-24.
Kazlauskaite R, Evans AT, Villabona CV, et al. Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis. J Clin Endocrinol Metabol. 2008;93(11):4245-4253.
Sbardella E, Isidori AM, Woods CP, et al. Baseline morning cortisol level as a predictor of pituitary-adrenal reserve: a comparison across three assays. Clin Endocrinol. 2017;86(2):177-184.
Pofi R, Feliciano C, Sbardella E, et al. The short synacthen (Corticotropin) test can be used to predict recovery of Hypothalamo-Pituitary-Adrenal axis function. J Clin Endocrinol Metabol. 2018;103(8):3050-3059.
Pofi R, Gunatilake S, Macgregor V, et al. Recovery of the Hypothalamo-Pituitary-Adrenal axis after transsphenoidal adenomectomy for Non-ACTH-Secreting macroadenomas. J Clin Endocrinol Metabol. 2019;104(11):5316-5324.
Butt MI, Alzuhayri N, Amer L, et al. Comparing the utility of 30- and 60-minute cortisol levels after the standard short synacthen test to determine adrenal insufficiency: a retrospective cross-sectional study. Medicine. 2020;99(43):e22621.
Michaelidou M, Yadegarfar G, Morris L, et al. Recalibration of thinking about adrenocortical function assessment: how the ‘random’ cortisol relates to the short synacthen test results. Cardiovasc Endocrinol Metabol. 2021;10(2):137-145.
Ramadoss V, Lazarus K, Prevost AT, Tan T, Meeran K, Choudhury S. Improving the interpretation of afternoon cortisol levels and SSTs to prevent misdiagnosis of adrenal insufficiency. J Endocr Soc. 2021;5(11):bvab147.
Perton FT, Mijnhout GS, Kollen BJ, Rondeel JM, Franken AA, Groeneveld PH. Validation of the 1 μg short synacthen test: an assessment of morning cortisol cut-off values and other predictors. Neth J Med. 2017;75(1):14-20.
Le Roux C, Meeran K, Alaghband-Zadeh J. Is a 0900-h serum cortisol useful prior to a short synacthen test in outpatient assessment? Ann Clin Biochem. 2002;39(Pt 2):148-150.
Lee MT, Won JG, Lee TI, Yang HJ, Lin HD, Tang KT. The relationship between morning serum cortisol and the short ACTH test in the evaluation of adrenal insufficiency. Zhonghua yi xue za zhi = Chinese medical journal; Free China ed. 2002;65(12):580-587.